The effect of vitamin E supplementation on antioxidant enzyme activities and lipid peroxidation levels in hemodialysis patients

Clinica Chimica Acta

Volumn 338, Issue 1-2, 2003, Pages 91-98

  Giray, Belma ^a   Kan, Erdal ^b   Bali, Musa ^b   Hincal, Filiz ^a   Basaran, Nursen ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Antioxidant enzymes; Hemodialysis; Lipid peroxidation; Oxidative stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CATALASE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ERYTHROCYTE; EVALUATION; FEMALE; HEMODIALYSIS; HUMAN; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL; UREMIA; VITAMIN SUPPLEMENTATION;

FELIS CATUS;

EID: 0345448313     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.07.020     Document Type: Article

References (50)

1. Galli F., Canestrari F., Bellomo G. Pathophysiology of the oxidative stress and its implication in uremia and dialysis. Contrib. Nephrol. 127:1999;1-31.
2. Miyata T., Fu T.X., Kurokawa K., Thorpe S.R., Baynes J.W. Autooxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia? Kidney Int. 54:1998;1290-1295.
3. Giorillo C., Oliviero C., Rizzuti G., Nediani C., Pacini A., Nassi P. Oxidative stress and antioxidant defences in renal patients receiving regular hemodialysis. Clin. Chem. Lab. Med. 36:1998;149-153.
4. Hasselwander O., Young I.S. Oxidative stress in chronic renal failure. Free Radic. Res. 29:1998;1-11.
5. Galli F., Canestrari F., Buoncritiani U. Biological effects of oxidant stress in haemodialysis: the possible roles of vitamin E. Blood Purif. 17:1999;79-94.
6. Canaud B., Cristol J., Moreno M., leray-Moregues H., Bosc J., vaussenat F. Imbalance of oxidants and antioxidants in hemodialysis patients. Blood Purif. 17:1999;99-106.
7. Combe C., Pourtein M., Precigout V.et al. Granulocyte activation and adhesion molecules during hemodialysis with cuprophan and high flux biocompatible membrane. Am. J. Kidney Dis. 24:1994;437-442.
8. Kuwahara T., Market M., Wauters J.P. Neutrophil oxygen radical production by dialysis membranes. Nephrol. Dial. Transplant. 3:1988;661-665.
9. Iuliano L., Colavita A.R., Leo R., Pratico D., Violi F. Oxygen free radicals and platelet activation. Free Radic. Biol. Med. 22:1997;999-1006.
10. Foley R.N., Parfrey P.S., Sarnack M.J. Cardiovascular diseases in chronic renal failure. Am. J. Kidney Dis. 32:1998;S112-S119.
11. Rigatto C., Singal P.K. Oxidative stress in uremia: impact on cardiac disease in dialysis patients. Semin. Dial. 12:1999;91-96.
12. Locatelli F., Del Vecchio L., Manzoni C. Morbidity and mortality on maintenance hemodialysis. Nephron. 80:1998;380-400.
13. Lindsay R.M., Moorthy A.V., Koens F., Linton A.L. Platelet function in dialyzed patients with chronic renal failure. Clin. Nephrol. 4:1975;52-57.
14. Kikuchi Y., Koyama T., Koyama Y.et al. Red blood cell deformability in renal failure. Nephron. 30:1982;8-14.
15. Ritz E., Deppisch R., Sitier E., Hansch G. Atherogenesis and cardiac death: Are they related to dialysis procedure and biocompatibility? Nephrol. Dial. Transplant. 9:1994;165-172.
16. Huysmans K., Lins R.I., Daelemans R., Zachee P., DeBroe M.E. Hypertension and accelerated atherosclerosis in endstage renal disease. J. Nephrol. 11:1998;185-195.
17. Chow C.K. Vitamin E and oxidative stress. Free Radic. Biol. Med. 11:1991;215-232.
18. Riccralelli R., Tasinato A., Clement S., Ozer N.K., Boscoboinik D., Azzi A. Alpha tocopherol specially inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem. J. 15:1998;243-249.
19. Galli F., Rovidati S., Chiarantini L., Kulurianu H., Canestrari F., Buonaristani U. Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter. Kidney Int. 54:1998;580-589.
20. Devaraj S., Li D., Jialal E. The effect of alphatocopherol supplementation on monocyte function. J. Clin. Invest. 98:1996;756-763.
21. Chan A.C. Vitamin E and atherosclerosis. J. Nutr. 128:1998;1593-1596.
22. Bendich A. Antioxidant vitamins and human immune response. Litwack G. Vitamins and hormones. 1996;35-62 Academic Press, San Diego.
23. Satoh M., Yamasaki Y., Nagake Y.et al. Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int. 59:2001;1943-1950.
24. Galli F., Varga Z., Balla J.et al. Vitamin E, lipid profile and lipid peroxidation in hemodialysis patients. Kidney Int. 59:2001;S148-S154.
25. Cristol J.-P., Bosc J.-Y., Badiou S.et al. Erythropoetin and oxidative stress in hemodialysis: beneficial effects of vitamin E supplementation. Nephrol. Dial. Transplant. 12:1997;2312-2317.
26. Inal M., Kanbak G., Sen S., Yetkin I., Akyuz F. The effect of long-term vitamin E therapy on the antioxidant enzymes and lipid peroxidation in hemodialysis patients. Ann. Med. Sci. 8:1999;84-87.
27. Paglia D.E., Valentina W.N. Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70:1967;158-169.
28. Aebi H. Catalase. Bergmeyer H.U. Methods of enzymatic analysis. 1974;673-677 Academic Press, New York.
29. Marklund S., Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47:1974;469-474.
30. Richard M.J., Portal B., Meo J., Coudray C., Hadjian A., Favier A. Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clin. Chem. 38:1992;704-709.
31. Tetta C., Biasioli S., Schiavon R.et al. An overview of hemodialysis and oxidative stress. Blood Purif. 17:1999;118-126.
32. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine. 1989;Clarendon Press, Oxford.
33. Loughrey C.M., Young I.S., Lightbody J.H., Mc Master D., Mc Namee P.T., Trimble E.R. Oxidative stress in hemodialysis. OJM. 87:1994;679-683.
34. Cristol J.P., Canaud B., Rabesandratana H., Gailard I., Serre A., Mion C. Enhancement of reactive oxygen species production and cell surface markers expression due to hemodialysis. Nephrol. Dial. Transplant. 9:1994;389-394.
35. Naito H., Azuma M., Hashimoto Y. Clinical assessment of dialyzer using regenerated cellulose membrane with modified surface. Clin. Rep. 28:1994;589-595.
36. Chen C., Liaw J., Juang J., Lin T. Antioxidant enzymes and trace elements in hemodialyzed patients. Biol. Trace Elem. Res. 58:1997;149-157.
37. Durak I., Akyol O., Basesme E., Canbolat O., Kavutcu M. Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure. Nephron. 66:1994;76-80.
38. Turi S., Nemeth I., Vargha I., Matkovicks B., Dubos E. Erythrocyte defense mechanisms against free oxygen radicals in hemodialyzed uremic children. Pediatr. Nephrol. 5:1991;179-183.
39. Paul J.-L., Sall N.-D., Soni T.et al. Lipid peroxidation abnormalities in hemodialyzed patients. Nephron. 64:1993;106-109.
40. Asoyama K., Shiki Y., Ito H.et al. Antioxidant enzymes and lipoperoxide in blood in uremic children and adolescents. Free Radic. Biol. Med. 9:1990;105-109.
41. Taccone-Gallucci M., Giardini O., Ausiello C.et al. Vitamin E supplementation in hemodialysis patients: effect on peripheral blood mononuclear cells lipid peroxidation and immune response. Clin. Nephrol. 25:1986;81-86.
42. Giardini O., Taccone-Gallucci M., Lubrano R.et al. Effects of alpha-tocopherol administration on red blood cell membrane lipid peroxidation in hemodialysis patients. Clin. Nephrol. 21:1984;174-177.
43. Dasgupta A., Hussain S., Ahmad S. Increased lipid peroxidation in patients on maintenance hemodialysis. Nephron. 60:1992;56-59.
44. Daschner M., Lenhartz H., Botticher D., Schaefer F., Wollschlager M., Mehls O. Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. Kidney Int. 50:1996;1268-1272.
45. Erdogan C., Unlucerci Y., Turkmen A., Kuru A., Cetin O., Bekpinar S. The evaluation of oxidative stress in patients with chronic renal failure. Clin. Chim. Acta. 322:2002;157-161.
46. Wratten M.L., Navino C., Tetta C., Verzetti G. Hemolipodialysis. Blood Purif. 17:1999;127-133.
47. Mydlik M., Derzsiova K., Racz O., Sipulova A., Lovasova E., Petrovicova J. A modified dialyzer with vitamin E and antioxidant defense parameters. Kidney Int. 59:2001;S144-S147.
48. Bayes B., Pastor M.C., Bonal J., Junca J., Romero R. Homocysteine and lipid peroxidation in hemodialysis: role of folinic acid and vitamin E. Nephrol. Dial. Transplant. 16:2001;2172-2175.
49. Cachia O., Leger C.L., Descomps B. Monocyte superoxide production is highly sensitive and inversely related to normal changes of low density lipoprotein in alpha tocopherol. Atherosclerosis. 138:1998;263-269.
50. Boaz M., Smetana S., Weinstein T.et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomized placebo-controlled trial. Lancet. 356:2000;1213-1218.